ebomi
Colour theme
Sign in
Insider · CIK 0001253170

Akkaraju Srinivas

CIK 0001253170 Name as filed on the most recent filing

Filed as Akkaraju Srinivas (92)

227 transaction lines · from 92 filings · filed 2004-06-04 to 2026-05-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

188 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-05-20 P, Open-market purchase Kalaris Therapeutics, Inc.KLRS 1,179,969, acquired Open Form 4 filing 0001231919-26-000532
2026-01-09 P, Open-market purchase Alumis Inc.ALMS 9,999,995, acquired Open Form 4 filing 0001253170-26-000004
2025-12-18 P, Open-market purchase Kalaris Therapeutics, Inc.KLRS 5,000,006, acquired Open Form 4 filing 0001231919-26-000166
2025-12-05 P, Open-market purchase Alumis Inc.ALMS 3 lines 1,833,760, acquired Open Form 4 filing 0001253170-25-000021
2025-12-04 P, Open-market purchase Alumis Inc.ALMS 540,101, acquired Open Form 4 filing 0001253170-25-000019
2025-12-03 P, Open-market purchase Alumis Inc.ALMS 775,000, acquired Open Form 4 filing 0001253170-25-000019
2025-12-02 P, Open-market purchase Alumis Inc.ALMS 724,800, acquired Open Form 4 filing 0001253170-25-000019
2025-12-01 P, Open-market purchase Alumis Inc.ALMS 644,171, acquired Open Form 4 filing 0001253170-25-000017
2025-11-28 P, Open-market purchase Alumis Inc.ALMS 295,683, acquired Open Form 4 filing 0001253170-25-000017
2025-11-26 P, Open-market purchase Alumis Inc.ALMS 370,823, acquired Open Form 4 filing 0001253170-25-000017
2025-11-20 P, Open-market purchase Alumis Inc.ALMS 905,350, acquired Open Form 4 filing 0001253170-25-000014
2025-11-19 P, Open-market purchase Alumis Inc.ALMS 903,784, acquired Open Form 4 filing 0001253170-25-000011
2025-11-18 P, Open-market purchase Alumis Inc.ALMS 621,045, acquired Open Form 4 filing 0001253170-25-000011
2025-11-17 P, Open-market purchase Alumis Inc.ALMS 5,036, acquired Open Form 4 filing 0001253170-25-000011
2025-11-13 P, Open-market purchase Alumis Inc.ALMS 1,449,940, acquired Open Form 4 filing 0001253170-25-000008
2025-10-07 P, Open-market purchase Scholar Rock Holding CorpSRRK 3 lines 1,181,634, acquired Open Form 4 filing 0001253170-25-000025
2025-10-06 P, Open-market purchase Scholar Rock Holding CorpSRRK 3 lines 4,368,808, acquired Open Form 4 filing 0001253170-25-000006
2025-10-03 P, Open-market purchase Scholar Rock Holding CorpSRRK 3 lines 14,438,544, acquired Open Form 4 filing 0001253170-25-000006
2025-09-04 P, Open-market purchase Mineralys Therapeutics, Inc.MLYS 14,999,993, acquired Open Form 4 filing 0001415889-25-023919
2025-05-05 P, Open-market purchase Alumis Inc.ALMS 2 lines 749,676, acquired Open Form 4 filing 0001415889-25-012166
2025-05-02 P, Open-market purchase Alumis Inc.ALMS 727,636, acquired Open Form 4 filing 0001415889-25-012166
2025-03-13 P, Open-market purchase Mineralys Therapeutics, Inc.MLYS 8,100,000, acquired Open Form 4 filing 0001415889-25-008274
2024-11-26 P, Open-market purchase Neurogene Inc.NGNE 4 lines 1,259,623, acquired Open Form 4 filing 0001415889-24-027861
2024-10-07 S, Open-market sale Scholar Rock Holding CorpSRRK 3 lines 34,385,673, disposed Open Form 4 filing 0001415889-24-024852
2024-07-01 P, Open-market purchase Alumis Inc.ALMS 25,000,000, acquired Open Form 4 filing 0001415889-24-022292
2024-05-30 P, Open-market purchase Cargo Therapeutics, Inc.CRGX 4,998,000, acquired Open Form 4 filing 0001415889-24-015250
2023-12-21 P, Open-market purchase Syros Pharmaceuticals, Inc.SYRS 3,999,998, acquired Open Form 4 filing 0001209191-23-059693
2023-11-14 P, Open-market purchase Cargo Therapeutics, Inc.CRGX 9,999,990, acquired Open Form 4 filing 0001209191-23-055621
2023-10-16 P, Open-market purchase Scholar Rock Holding CorpSRRK 15,000,000, acquired Open Form 4 filing 0001209191-23-053113
2023-02-14 P, Open-market purchase Mineralys Therapeutics, Inc.MLYS 15,000,000, acquired Open Form 4 filing 0001628280-23-003923
2022-05-27 P, Open-market purchase Chinook Therapeutics, Inc.KDNY 7,980,000, acquired Open Form 4 filing 0001209191-22-033141
2022-04-12 P, Open-market purchase Graphite Bio, Inc.GRPH 1,428,000, acquired Open Form 4 filing 0001209191-22-024364
2022-04-11 P, Open-market purchase Graphite Bio, Inc.GRPH 303,068, acquired Open Form 4 filing 0001209191-22-024364
2022-01-24 P, Open-market purchase Graphite Bio, Inc.GRPH 200,100, acquired Open Form 4 filing 0001209191-22-004735
2022-01-21 P, Open-market purchase Graphite Bio, Inc.GRPH 899,000, acquired Open Form 4 filing 0001209191-22-004735
2022-01-20 P, Open-market purchase Graphite Bio, Inc.GRPH 384,497, acquired Open Form 4 filing 0001209191-22-004346

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 68
  • Open-market sale 120
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. AKKARAJU SRINIVAS, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001253170

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.